Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private, purchasing the remaining 50 percent ownership interest from Granules India.
read more
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna to create a new generation of transformative medicines for patients.
read more
Flamma announced the ground breaking for their new R&D building.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level.
read more
CGT Catapult announced Achilles will manufacture their advanced therapy products for clinical trials in one of the newly operational modules at the CGT Catapult manufacturing center.
read more
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO.
read more
SwiftScale Biologics has successfully manufactured a COVID-19 neutralizing antibody candidate at clinical scale.
read more
AdvantaPure is now a GORE STA-PURE Pump Tubing systems integrator for biopharm and pharmaceutical applications.
read more
Lupin is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP 500mg, lot G901203 to the consumer level.
read more
Almac Group has reported an £85.4 million rise in turnover from £548.9 million to £634.3 million for its financial year 2018-19.
read more
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
Mapi Pharma announced an additional investment from Mylan in support of continued study progress to bring to market in the U.S. Glatiramer Acetate Depot.
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more